HC Wainwright & Co. Initiates Coverage On AngioDynamics With Buy Rating, Announces Price Target of $19
HC Wainwright & Co. Initiates Coverage On AngioDynamics With Buy Rating, Announces Price Target of $19
HC Wainwright & Co.以買入評級開始對AngiOdynamics進行報道，宣佈目標股價爲19美元
HC Wainwright & Co. analyst Yi Chen initiates coverage on AngioDynamics (NASDAQ:ANGO) with a Buy rating and announces Price Target of $19.
HC Wainwright&Co.分析師陳毅在AngioDynamic(納斯達克代碼：ANGO)上以買入評級開始報道，並宣佈目標價為19美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。